Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac) - 28/02/23
Doi : 10.1016/j.jinf.2022.12.016
Xue Li a, b, c, 1, Kuan Peng a, 1, Franco W.T. Cheng b, David C.L. Lam a, Ching Lung Cheung b, c, Celine S.L. Chui c, d, e, Francisco T.T. Lai b, c, Eric Y.F. Wan b, c, f, Carlos K.H. Wong b, c, f, Tiantian Ma b, c, Samson H.H. Yum g, Esther W.Y. Chan b, c, Jian Dong Huang i, Chak Sing Lau a, Mary S.M. Ip a, Ian C.K. Wong b, c, h, ⁎ 
a Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
b Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
c Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong
d School of Nursing, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
e School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
f Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
g Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
h Research Department of Practice and Policy, UCL School of Pharmacy, Hong Kong
i School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
⁎Corresponding author at: Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, 2/F Laboratory Block, 21 Sassoon Road, Pok Fu Lam, Hong Kong.Department of Pharmacology and Pharmacy, LKS Faculty of Medicine2/F Laboratory Block, 21 Sassoon RoadPok Fu LamHong Kong
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : COVID-19 vaccines, Innate immunity, Tuberculosis
Le texte complet de cet article est disponible en PDF.
Plan
| Short summary: Both the mRNA and the inactivated virus SARS-CoV-2 vaccine potentially offer a protective effect on TB |
© 2022
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 86 - N° 3
P. 256-308 - mars 2023 Retour au numéro
Article précédent
- Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents
- Manuel Krone, Isabell Wagenhäuser, Kerstin Knies, Daniela Hofmann, Geraldine Engels, Regina Taurines, Miriam McDonogh, Sven Flemming, Thomas Meyer, Hartmut Böhm, Agmal Scherzad, Michael Eisenmann, Vera Rauschenberger, Alexander Gabel, Nils Petri, Julia Reusch, Johannes Forster, Benedikt Weißbrich, Lars Dölken, Oliver Kurzai, Ulrich Vogel, Christoph Härtel, Johannes Liese, Oliver Andres
- Changes of Mycoplasma pneumoniae infection in children before and after the COVID - 19 pandemic, Henan, China
- Ying Liang, Pin Zhang, Bang Du, Xianwei Zhang, Guangjun Hou, Wancun Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.